Showing results (351-360 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|October 11, 2005
The use of Monte Carlo simulations to study the effect of poor compliance on the steady state concentrations of valproic acid following administration of enteric-coated and extended release divalproex sodium formulationsAlaa M Ahmad, F Douglas Boudinot, William H Barr, et al.Biopharmaceutics & Drug Disposition|May 21, 2005
The influence of weight with assay error on gentamicin pharmacokinetics using the Bayesian and nonlinear least square regression analysis in appendicitis patientsJin Pil BurmBiopharmaceutics & Drug Disposition|June 22, 2005
Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat modelsAnooshirvan Shayeganpour, Andrew S Jun, Dion R BrocksBiopharmaceutics & Drug Disposition|June 14, 2006
Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteersLaurian Vlase, Adrian Leucuta, Dorin Farcau, et al.Biopharmaceutics & Drug Disposition|January 1, 1994
Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatmentM Bialer, S Hadad, G Golomb, et al.Biopharmaceutics & Drug Disposition|January 1, 1995
The influence of pregnancy on the biotransformation and urinary excretion of methoxyphenamine in miceB C Foster, D L Wilson, T D Cyr, et al.Biopharmaceutics & Drug Disposition|January 1, 1995
An in vitro study of the influence of a drug's molecular weight on its overall (Clt), diffusive (Cld) and convective (Clc) clearance through dialysersM V Mac-Kay, I P Fernandez, J Herrera Carranza, et al.Biopharmaceutics & Drug Disposition|April 1, 1995
The influence of pyruvic acid on the pharmacokinetics of sulphadiazine in rabbitsK Y Hsu, D J Song, Y HoBiopharmaceutics & Drug Disposition|March 1, 1995
Uptake and biodisposition of 2-ylcyanamide-1,3,4-thiadiazole (LY217896) by red blood cellsP L Bonate, A PeytonBiopharmaceutics & Drug Disposition|March 1, 1994
Comparative in vitro and in vivo bioavailability of naproxen from tablet and caplet formulationsB G Charles, G A MoggPageof 214